Tech Company Financing Transactions
Integra Therapeutics Funding Round
Integra Therapeutics, based in Barcelona, secured $12.5 million from AdBio Partners, CDTI and Columbus Venture Partners.
Transaction Overview
Company Name
Announced On
9/8/2025
Transaction Type
Venture Equity
Amount
$12,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to incorporate new advances into the FiCAT gene writing platform, validate various next generation CAR-T therapies in the preclinical phase and expand the FiCAT cell engineering capabilities to facilitate technology transfer to the pharmaceutical industry.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Av. Diagonal, 601, 8th Floor
Barcelona, 08028
Spain
Barcelona, 08028
Spain
Phone
Undisclosed
Website
Email Address
Overview
At Integra Therapeutics we are committed to create new gene writing tools that help to improve the scope, efficiency and safety of advanced therapies. Our purpose is to cure genetic, oncological and autoimmune diseases with high unmet medical need.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Avencia Sánchez-Mejías
Browse more venture capital transactions:
Prev: 9/8/2025: Rainforest Pay venture capital transaction
Next: 9/8/2025: BranchLab venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs